Community Oncology

Elsevier BV

Peer review: Peer review
Evaluation status available after sign-in

About the journal

Community Oncology is a journal published by Elsevier BV in United States. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2331-4435 · 1548-5315
Country
United States
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • PUBMED · 2008-11-01
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Dormant — no works recorded since 2013
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1297

Last recorded publication year

2013

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

23

i10-index

60

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity1
Source type
journal
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Healthcare Policy and Management
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Breast Cancer Treatment Studies
  • Economic and Financial Impacts of Cancer
  • Cancer survivorship and care
  • Advances in Oncology and Radiotherapy
  • Palliative and Oncologic Care
Show all subjects (75)
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Advances in Oncology and Radiotherapy
  • BRCA gene mutations in cancer
  • Advances in Oncology and Radiotherapy
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Pharmaceutical Economics and Policy
  • Lung Cancer Treatments and Mutations
  • Chronic Lymphocytic Leukemia Research
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Treatments and Studies
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Bone health and treatments
  • Lung Cancer Diagnosis and Treatment
  • Health Services Management and Policy
  • Chronic Lymphocytic Leukemia Research
  • Global Cancer Incidence and Screening
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Patient-Provider Communication in Healthcare
  • Neutropenia and Cancer Infections
  • Healthcare Quality and Management
  • BRCA gene mutations in cancer
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Electronic Health Records Systems
  • Colorectal Cancer Surgical Treatments
  • Multiple Myeloma Research and Treatments
  • Science, Research, and Medicine
  • Science, Research, and Medicine
  • HER2/EGFR in Cancer Research
  • Palliative Care and End-of-Life Issues
  • Chronic Myeloid Leukemia Treatments
  • Palliative Care and End-of-Life Issues
  • Chronic Myeloid Leukemia Treatments
  • Healthcare Policy and Management
  • Healthcare Policy and Management
  • Biotechnology and Related Fields
  • Biotechnology and Related Fields
  • Prostate Cancer Treatment and Research
  • Biomedical Ethics and Regulation
  • Prostate Cancer Treatment and Research
  • Biomedical Ethics and Regulation
  • Cancer Diagnosis and Treatment
  • Pharmaceutical Economics and Policy
  • Primary Care and Health Outcomes
  • Chemotherapy-related skin toxicity
  • Chemotherapy-related skin toxicity
  • Cancer Diagnosis and Treatment
  • Pharmaceutical Economics and Policy
  • Primary Care and Health Outcomes
  • Bone health and treatments
  • Bone health and treatments
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: